2026 AASLD The Liver Meeting in Denver

2026 AASLD The Liver Meeting in Denver
Treatment Adherence & Healthcare Utilization in PBC In a real-world cohort of over 54,000 U.S. patients with primary biliary cholangitis (PBC), only about half achieved ≥80% treatment adherence in the first year, and adherence declined further over time. Patients who stayed adherent had significantly lower rates of cirrhosis, decompensated cirrhosis, liver transplant, and death, along with fewer inpatient, ER, and outpatient visits — though they filled more prescriptions, pointing to adherence-friendly therapies as a lever for both better outcomes and lower healthcare costs.
PBC.Care Web Apps for Shared Decision-Making A national patient-provider education initiative (PBC.Care, developed by PRIME Education) found major communication gaps driving undertreatment: only 34% of patients felt knowledgeable about when to consider second-line therapy, and 43% of providers cited convincing patients of its safety/efficacy as their top barrier to escalating care. After engaging with the companion web apps, provider confidence rose sharply — from 49% to 78% in diagnosis/symptom assessment and 51% to 65% in evaluating first-line treatment response (both p<.0001) — suggesting tethered patient-provider tools can meaningfully improve shared decision-making in PBC.
